With over 15 years of experience in the Romanian pharmaceutical market, Elena Barbu joins MAYOLY as Country Lead in Romania, effective October 19, 2026. Her commercial expertise, in-depth knowledge of the sector and proven experience in developing strategic partnerships will be valuable assets in supporting the subsidiary’s growth.
This appointment reflects MAYOLY’s development ambitions in Central and Eastern Europe (CEE), where Romania is a strategic market for the Group. It demonstrates MAYOLY’s commitment to driving growth by leveraging strong local market knowledge, engaged leadership and long-term partnerships.
Welcome to MAYOLY, Elena, and best wishes for success in your new role !
With 15 years of experience in consumer healthcare and fast-moving consumer goods, Thomas will be responsible for supporting MAYOLY’s growth across Central and Eastern Europe and strengthening the Group’s presence in this strategic region. This appointment reflects MAYOLY’s ambition to accelerate its international development by relying on recognized talents and pursuing its mission: delivering innovative and accessible healthcare solutions for patients and healthcare professionals. Welcome to MAYOLY, Thomas, and best wishes for this new entrepreneurial journey!
Mayoly appoints a new executive committee to support its ambitious development goals
Mayoly Spindler completes the acquisition of Pharm Nature
Mayoly Spindler completes the acquisition of Pharm Nature
Mayoly Spindler completed the acquisition of Ipsen’s CHC branch
Mayoly Spindler acquires Pharm Nature and strengthens its position in natural food supplements
Dear all,
I am very pleased to inform you that the Mayoly group has acquired the company BeauTerra, a French laboratory which specializes in the design and marketing of natural and environmentally friendly personal hygiene products, 100% Made in France. This investment in BeauTerra allows us to broaden our dermo-cosmetic offer.
The personal hygiene market currently represents a third of the dermo-cosmetics market in France.
With an increase in consumer sales of 250% and 2.2 million products sold in 2020, BeauTerra was the third largest contributor to last year’s growth in the French dermo-cosmetics market.
An exceptional success (in just 4 years!) which stems from the creativity and responsiveness of its human-scale team and the effectiveness of its business model, which is based on the digitalization of the relationship between the brand and its 3,800 pharmacy customers.
Alongside Hugo Le Morvan, its Founding-Director, as well as his team, Mayoly Spindler will provide BeauTerra access to its strong sales & logistics resources and its expertise in product and regulatory development to successfully pursue the brand’s growth in France, but also on an international level.
The very short-term objectives will be as follows:
- Strengthen BeauTerra’s position in France and develop turnover so that success can continue
- Accelerate the development of the brand by launching new ranges and references
- Select the international countries for which BeauTerra and its development model will be a success
Please find attached the press releases. The operations to enable BeauTerra to benefit from Mayoly Spindler’s strengths & resources have already started and will continue in the forthcoming weeks.
Yours Sincerely,
P.
Positive results of a cost effectiveness study presented at the XXXIst International Workshop on Helicobacter & Microbiota in Inflammation and Cancer on September 14, 2018 in Kaunas (Lithuania). Data show that in patients with uninvestigated dyspepsia, the “Test and Treat” strategy incorporating Urea Breath Test as implemented in Spain is as effective and more cost effective than the Endoscopy-only strategy with regard to dyspepsia relief and gastric cancer prevention.